Article

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapy

2013-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b7bfec62-9bb0-5e2a-8018-3b6e8007d5d5
DOI: 10.1186/2051-1426-1-s1-p63
PMCID: PMC3991192

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic inference of immune responsiveness of melanoma cancer patients to TIL therapyDOI 10.1186/2051-1426-1-s1-p63Read

The impact of melanoma genetics on treatment response and resistance in clinical and experimental studiesSemantic proximity Read

Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaSemantic proximity Read

Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approachSemantic proximity Read

The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.Semantic proximity Read

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable DiseaseSemantic proximity Read

Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical CharacteristicsSemantic proximity Read

Decoding the genetic basis of anti-tumor immunity.Semantic proximity Read

Disentangling the relationship between tumor genetic programs and immune responsivenessSemantic proximity Read

HLA Genotype is Associated With Clinical Outcomes to anti-PD1 Therapy in Advanced MelanomaSemantic proximity Read

Association between cancer risk and HLA genotype can be explained by anti-tumor immunitySemantic proximity Read

Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanomaSemantic proximity Read

MHC class I and class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanomaSemantic proximity Read